PRKAG2 Gene Glycogen Storage Disease of Heart Lethal Genetic Test
Are you concerned about glycogen storage disease of the heart? DNA Labs UAE offers the PRKAG2 Gene Glycogen Storage Disease of Heart Lethal Genetic Test to provide accurate diagnosis and management options. Let’s explore the details of this genetic test:
Test Components and Price
- Test Name: PRKAG2 Gene Glycogen Storage Disease of Heart Lethal Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the PRKAG2 Gene Glycogen Storage Disease of Heart Lethal Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session may be conducted to draw a pedigree chart of family members affected by glycogen storage disease of the heart (lethal).
Test Details
The PRKAG2 gene encodes the protein known as 5′-AMP-activated protein kinase (AMPK). This protein plays a crucial role in regulating energy metabolism in cells, including the heart muscle cells. Glycogen storage disease of the heart (GSD-Heart) is a rare genetic disorder caused by mutations in the PRKAG2 gene. It is characterized by the abnormal accumulation of glycogen in the heart muscle, leading to impaired cardiac function.
Individuals affected by GSD-Heart may experience symptoms such as heart failure, arrhythmias, and sudden cardiac death. To identify mutations in the PRKAG2 gene that may be causing the disease, NGS (Next-Generation Sequencing) genetic testing is used. This testing method allows for a comprehensive and efficient analysis of the gene, enabling healthcare professionals to make an accurate diagnosis and provide appropriate management and treatment options.
Overall, the PRKAG2 gene NGS genetic test is an important tool in the diagnosis and management of glycogen storage disease of the heart. It provides valuable information for both patients and healthcare providers, allowing for personalized care and treatment.
Test Name | PRKAG2 Gene Glycogen storage disease of heart lethal Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PRKAG2 Gene Glycogen storage disease of heart (lethal) NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease of heart (lethal) |
Test Details |
The PRKAG2 gene is responsible for encoding the protein known as 5′-AMP-activated protein kinase (AMPK). This protein plays a crucial role in regulating energy metabolism in cells, including the heart muscle cells. Glycogen storage disease of the heart (GSD-Heart) is a rare genetic disorder caused by mutations in the PRKAG2 gene. It is characterized by the abnormal accumulation of glycogen in the heart muscle, leading to impaired cardiac function. This condition is usually lethal, and affected individuals may experience symptoms such as heart failure, arrhythmias, and sudden cardiac death. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of GSD-Heart, NGS genetic testing can be used to identify mutations in the PRKAG2 gene that may be causing the disease. This testing method allows for a more comprehensive and efficient analysis of the gene, enabling healthcare professionals to make an accurate diagnosis and provide appropriate management and treatment options. Overall, PRKAG2 gene NGS genetic testing is an important tool in the diagnosis and management of glycogen storage disease of the heart, providing valuable information for both patients and healthcare providers. |